These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 30238767

  • 21. Dabigatran-induced esophagitis: A frequently overlooked adverse effect.
    Zhang N, Liu XS, Li G, Liu T.
    Int J Cardiol; 2016 Jun 01; 212():358-9. PubMed ID: 27057956
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age.
    Abe J, Umetsu R, Kato Y, Ueda N, Nakayama Y, Suzuki Y, Suzuki T, Nagasawa H, Kinosada Y, Nakamura M.
    Int J Med Sci; 2015 Jun 01; 12(4):312-21. PubMed ID: 25897292
    [Abstract] [Full Text] [Related]

  • 23. [Life-threatening bleeding during dabigatran treatment because of acute renal failure].
    Madsen HB, Lütken SC, Povlsen JA, Løfgren B.
    Ugeskr Laeger; 2014 Jun 01; 176(34):. PubMed ID: 25293571
    [Abstract] [Full Text] [Related]

  • 24. Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
    Kolb JM, Flack KF, Chatterjee-Murphy P, Desai J, Wallentin LC, Ezekowitz M, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J.
    Dig Dis Sci; 2018 Jul 01; 63(7):1878-1889. PubMed ID: 29582237
    [Abstract] [Full Text] [Related]

  • 25. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H, El-Makaty H, Ali Z.
    J Cardiovasc Pharmacol Ther; 2018 Mar 01; 23(2):155-161. PubMed ID: 28978236
    [Abstract] [Full Text] [Related]

  • 26. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    Eek AK, Øie E, Granas AG.
    Eur J Clin Pharmacol; 2018 Mar 01; 74(3):323-330. PubMed ID: 29149366
    [Abstract] [Full Text] [Related]

  • 27. [Thrombosis of a mechanical prosthetic mitral valve during dabigatran treatment].
    Thomsen JH, Kjaergaard J, Saust LT, Wachtell K, Hassager C.
    Ugeskr Laeger; 2014 Mar 17; 176(12A):. PubMed ID: 25350892
    [Abstract] [Full Text] [Related]

  • 28. [Nosebleed in new oral anticoagulant treatment - what should be done?].
    Stiefelhagen P.
    MMW Fortschr Med; 2015 Sep 10; 157(15):25. PubMed ID: 26349711
    [No Abstract] [Full Text] [Related]

  • 29. Analysis of the clinical characteristics of dabigatran-induced oesophagitis.
    Zhou Y, Su Y, Li Z, Wu C, Sun W, Wang C.
    Eur J Hosp Pharm; 2023 Mar 10; 30(e1):e24-e28. PubMed ID: 34301743
    [Abstract] [Full Text] [Related]

  • 30. Thrombocytopenia induced by dabigatran: two case reports.
    Kang HG, Lee SJ, Chung JY, Cheong JS.
    BMC Neurol; 2017 Jun 29; 17(1):124. PubMed ID: 28662704
    [Abstract] [Full Text] [Related]

  • 31. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB, Swanson MT.
    Oral Maxillofac Surg Clin North Am; 2016 Nov 29; 28(4):515-521. PubMed ID: 27624772
    [Abstract] [Full Text] [Related]

  • 32. Successful hemostasis and reversal of highly elevated PT/INR after dabigatran etexilate use in a patient with acute kidney injury.
    Jones JM, Ryan HM, Tieszen M, Leedahl DD.
    Am J Emerg Med; 2016 Apr 29; 34(4):758.e5-6. PubMed ID: 26324007
    [Abstract] [Full Text] [Related]

  • 33. Dabigatran-related leukocytoclastic vasculitis.
    An J, Garje R, Wanat KA, Leone JP.
    BMJ Case Rep; 2017 Jan 04; 2017():. PubMed ID: 28052946
    [Abstract] [Full Text] [Related]

  • 34. New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report.
    Arcadi FA, Portaro S, Giorgianni R, Naro A, Casella C, Genovese C, Marino S, Calabrò RS.
    Medicina (Kaunas); 2019 Mar 17; 55(3):. PubMed ID: 30884868
    [Abstract] [Full Text] [Related]

  • 35. Very Late-Onset Dabigatran-Induced Esophageal Injury.
    Fujikawa K, Takasugi N, Goto T, Minatoguchi S.
    Can J Cardiol; 2017 Apr 17; 33(4):554.e15-554.e16. PubMed ID: 28343609
    [Abstract] [Full Text] [Related]

  • 36. Idarucizumab for dabigatran overdose in a child.
    Shapiro S, Bhatnagar N, Khan A, Beavis J, Keeling D.
    Br J Haematol; 2018 Feb 17; 180(3):457-459. PubMed ID: 27734469
    [No Abstract] [Full Text] [Related]

  • 37. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
    Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S.
    Stroke; 2017 Jan 17; 48(1):159-166. PubMed ID: 27909200
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran.
    Chenoweth JA, Johnson MA, Shook L, Sutter ME, Nishijima DK, Holmes JF.
    West J Emerg Med; 2017 Aug 17; 18(5):794-799. PubMed ID: 28874930
    [Abstract] [Full Text] [Related]

  • 39. Management of dabigatran after overdosage: two case reports and suggestions for monitoring.
    Billoir P, Girault C, Barbay V, Boyer D, Grangé S, Fresel M, Chrétien MH, Le Cam Duchez V.
    Blood Coagul Fibrinolysis; 2018 Nov 17; 29(7):653-655. PubMed ID: 30045050
    [Abstract] [Full Text] [Related]

  • 40. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.
    Yoshio T, Tomida H, Iwasaki R, Horiuchi Y, Omae M, Ishiyama A, Hirasawa T, Yamamoto Y, Tsuchida T, Fujisaki J, Yamada T, Mita E, Ninomiya T, Michitaka K, Igarashi M.
    Dig Endosc; 2017 Sep 17; 29(6):686-694. PubMed ID: 28295638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.